Since 2010, Laurie has led the company’s global health literacy efforts in support of improved patient communications, including medication labeling, packaging, clinical trial materials, and patient education. She has recently expanded her role to include health equity and social determinants of health, with a focus on oncology.  Laurie has worked to include respondents with low health literacy into patient labeling research, earning a national health literacy award.  She works and speaks internationally.  She has co-chaired two US working groups on lay summaries and health literacy in clinical trials, at the MRCT (Multi-Regional Clinical Trials Center of Brigham and Women’s and Harvard).  She served as an invited member of the EMA lay summaries working group, where she helped to influence guidance to reflect principles of health literacy, numeracy and readability.  She was an invited speaker by the FDA at a 2017 labeling conference, with an international audience of over 2000 people in 42 countries. She has delivered many keynote talks, including at SCOPE (Summit for Clinical Ops Executives) with 2300 people, ISMPP (Medical Publications), Women’s Leadership Conference, and the Asia Health Literacy Conference.  She has co-authored multiple publications and serves on the US National Academies Health Literacy Roundtable.  She won an MM&M Top 40 Healthcare Transformers Award.  She serves on the company’s Diversity Business Consortium, with health literacy as a key priority.  She is a passionate ally of the company’s Employee Resource Groups, co-chairing a working group on mutual mentorship for the League of Employees of African Descent.  She has a bachelor’s degree from Yale and an MBA from Wharton.  She lives in Pennsylvania with her husband, two daughters and three dogs!